TABLE 6.

Relationship between MIC and outcome for treatment of invasive candidiasis with andidulafungin and micafungin^a

MIC (μg/ml)b	Results for:c
	Anidulafungin		Micafungin
	S/T	%	S/T	%
0.008	67/70	96
0.016	11/14	79	120/149	81
0.03	11/13	85	116/152	76
0.06	8/9	89	12/13	92
0.125	1/3	33	12/14	86
0.25	1/1	100	15/17	88
0.5	4/5	80	19/25	76
1	3/5	60	28/31	90.3
2	2/2	100	5/9	56 (71)d
Total	119/135	88	327/410	80
Total ≤2	119/135	88	327/410	80

^aData were compiled from references 30, 45, and 56.

^bMICs were determined in accordance with the standards of CLSI document M27-A3 (11). Total ≤2, total number of patients for whose isolates the drug MIC was 2 μg/ml or less.

^cS/T, number of patients successfully treated/total number treated.

^dFive of 7 patients infected with C. parapsilosis for which the MIC was 2 μg/ml were treated successfully.